Analysis of Biomarkers From Patients With Chorioretinal Diseases

Recruiting now

Conditions studied: Diabetic Retinopathy, Macular Degeneration

In brief

This study was conducted to investigate the levels of ocular biomarkers from the patients with chorioretinal diseases including diabetic retinopathy, retinal vascular diseases, age-related macular degeneration (dry and wet), and retinal degeneration.

Key facts

Study ID

NCT02026843

Run by

Kyungpook National University Hospital

People needed

100

Starts

2012-04-01

Expected to finish

2031-04-01

Last updated by the study team

2025-03-06

Who can join

Age: 20 and older, up to 80. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• age over 20 years
• patients requiring ophthalmologic treatments for different degrees of decreasing of visual acuity.
• patients with chorioretinal diseases including diabetic retinopathy, retinal vascular diseases, age-related macular degeneration (dry and wet), and retinal degeneration.
• control patients asking cataract surgery or vitrectomy for posterior segment nonproliferative disorders.

You may not qualify if…

• under the age of 20 years
• patients that received any anti-vascular endothelial growth factor agent for proliferative disease before taking sample of aqueous humor
• patients that did not signed the informed consent of the trial
• patients with intraocular inflammations or infections that requiring any pharmaceutical agent
• patients with recent ocular trauma

Where it is running

• Dong Ho Park — Daegu, Kyungsangpookdo, South Korea (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.